title: Hepatitis B virus in tenofovir-naive Chinese patients with chronic hepatitis B contains no mutation of rtA194T conferring a reduced tenofovir susceptibility.
authors.affiliation: Viral Hepatitis Research Laboratory, Institute of Infectious Diseases, Beijing 302 Hospital, Beijing 100039, China.
authors.forename: Yan
authors.initials: Y
authors.lastname: Liu
authors.forename: Chun-mei
authors.initials: CM
authors.lastname: Wang
authors.forename: Jun
authors.initials: J
authors.lastname: Cheng
authors.forename: Zhao-ling
authors.initials: ZL
authors.lastname: Liang
authors.forename: Yan-wei
authors.initials: YW
authors.lastname: Zhong
authors.forename: Xiao-qiang
authors.initials: XQ
authors.lastname: Ren
authors.forename: Zhi-hui
authors.initials: ZH
authors.lastname: Xu
authors.forename: Fabien
authors.initials: F
authors.lastname: Zoulim
authors.forename: Dong-ping
authors.initials: DP
authors.lastname: Xu
mesh_terms: D000225:Adenine / Q000031:analogs & derivatives* / Q000627:therapeutic use; D000328:Adult; D024882:Drug Resistance, Viral / Q000235:genetics; D005260:Female; D005784:Gene Amplification; D005838:Genotype; D006515:Hepatitis B virus / Q000235:genetics*; D019694:Hepatitis B, Chronic / Q000188:drug therapy*; D006801:Humans; D008297:Male; D008875:Middle Aged; D009154:Mutation; D063065:Organophosphonates / Q000627:therapeutic use*; D012194:RNA-Directed DNA Polymerase / Q000235:genetics*; D018894:Reverse Transcriptase Inhibitors / Q000627:therapeutic use*; D000068698:Tenofovir
chemical_list: D063065:Organophosphonates; D018894:Reverse Transcriptase Inhibitors; D000068698:Tenofovir; D012194:RNA-Directed DNA Polymerase; D000225:Adenine